未知的已知:氨氯地平中毒中的非心源性肺水肿,一项队列研究
该前瞻性队列研究于2017–2018年由瑞典毒物中心鼓励在需正性肌力药或血管加压药的氨氯地平中毒患者中留取血样,共纳入19例血氨氯地平>0.25 µg/mL的患者。4例(21%)死亡,1例接受VA-ECMO治疗。9例发生非心源性肺水肿,定义为需要正压通气且超声心动图左心室功能正常。作者结论:在连续、经分析确认的重度氨氯地平中毒中,非心源性肺水肿常见,占全队列47%、未发生完全血流动力学崩溃者的64%。
要点
- 在血氨氯地平>0.25 µg/mL的19例重度中毒患者中,9例(47%)发生非心源性肺水肿,定义为需正压通气且超声心动图左心室功能正常。
- 未进展为完全血流动力学崩溃的患者中,非心源性肺水肿发生率达64%。
- 全队列4例(21%)死亡,1例接受VA-ECMO治疗。
- 非心源性肺水肿在钙通道阻滞剂中毒中曾被认作罕见,本队列显示在重度氨氯地平中毒中并非少见。
适用人群与场景
- 2017–2018年瑞典毒物中心前瞻性鼓励留取血样的氨氯地平中毒患者,症状需正性肌力药或血管加压药治疗。
- 纳入标准:血氨氯地平水平>0.25 µg/mL。
诊断标准与关键阈值
- 非心源性肺水肿定义:需要正压通气且超声心动图左心室功能正常。
- 纳入血氨氯地平阈值:>0.25 µg/mL。
红旗征与不能漏的情况
- 需要正压通气且超声心动图左心室功能正常提示非心源性肺水肿。
- 需正性肌力药或血管加压药治疗的重度中毒。
- 完全血流动力学崩溃;本队列1例接受VA-ECMO治疗。
研究设计与关键结果
- 研究类型:前瞻性队列研究;样本量19例;人群:血氨氯地平>0.25 µg/mL的氨氯地平中毒患者;2017–2018年瑞典毒物中心鼓励留取血样,血样邮寄至瑞典国家法医委员会法医毒理学部定量。
- 主要结果:9例(47%)发生非心源性肺水肿(需正压通气且超声心动图左心室功能正常);未发生完全血流动力学崩溃的患者中占64%。
- 结局:4例(21%)死亡;1例接受VA-ECMO治疗。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在重度氨氯地平中毒(血氨氯地平>0.25 µg/mL、需正性肌力药或血管加压药)患者中,应警惕非心源性肺水肿,原文报告其占47%、未发生完全血流动力学崩溃者中占64%。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Context: Amlodipine is the most common calcium channel blocker (CCB) on the Swedish market, and poison center (PC) consultations for amlodipine overdoses are increasing. The clinical picture is dominated by vasodilation with relative preservation of cardiac function. CCBs selectively dilate vessels on the afferent side of the capillary network which, in states of preserved or increased blood flow may lead to edema formation, including non-cardiogenic pulmonary edema (NCPE). This complication has been considered rare in CCB poisoning. In this cohort study of nineteen amlodipine poisonings with high amlodipine blood levels, the incidence and clinical significance of NCPE in severe amlodipine poisoning are explored.Methods: During 2017-2018 the Swedish PC prospectively encouraged the gathering of blood samples in amlodipine poisonings with symptoms requiring treatment with inotropes or vasopressors. Samples were sent by mail to the Forensic Toxicology Division at the Swedish National Board of Forensic Medicine for screening and quantification of relevant toxicants. Patients with blood amlodipine levels >0.25 µg/mL were included in a cohort whose case details were gathered from medical records and PC-case notes with a special focus on signs of NCPE.Results: Nineteen patients met the blood amlodipine inclusion criteria. Four (21%) died and one patient was treated with VA-ECMO. Nine patients developed NCPE defined as a need for positive pressure ventilation (PPV) while having an echocardiographically normal left ventricular function.Conclusion: In this prospective cohort study of consecutive and analytically confirmed significant amlodipine poisonings NCPE was a common finding occurring in 47% of the whole cohort and in 64% of patients who did not go on to develop complete hemodynamic collapse.
参考来源
- Lindeman E, Ålebring J, Johansson A, et al. The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study. Clin Toxicol (Phila). 2020. PMID: 32114860. doi:10.1080/15563650.2020.1725034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。